BioCardia, Inc. (BCDA)
NASDAQ: BCDA · IEX Real-Time Price · USD
2.910
+0.030 (1.04%)
At close: Jul 19, 2024, 4:00 PM
2.850
-0.060 (-2.06%)
Pre-market: Jul 22, 2024, 7:12 AM EDT
BioCardia Market Cap
BioCardia has a market cap or net worth of $5.30 million as of July 22, 2024. Its market cap has decreased by -90.15% in one year.
Market Cap
5.30M
Enterprise Value
5.58M
1-Year Change
-90.15%
Ranking
Category
Stock Price
$2.91
Market Cap Chart
Since November 21, 2000, BioCardia's market cap has decreased from $58.94B to $5.30M, a decrease of -99.99%. That is a compound annual growth rate of -32.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 5.30M | -63.19% |
| Dec 29, 2023 | 14.40M | -61.39% |
| Dec 30, 2022 | 37.30M | 14.07% |
| Dec 31, 2021 | 32.70M | -23.95% |
| Dec 31, 2020 | 43.00M | 71.31% |
| Dec 31, 2019 | 25.10M | -42.69% |
| Dec 31, 2018 | 43.80M | -51.22% |
| Dec 29, 2017 | 89.80M | -63.96% |
| Dec 30, 2016 | 249.20M | 1,254.35% |
| Dec 31, 2015 | 18.40M | -27.27% |
| Dec 31, 2014 | 25.30M | 37.50% |
| Dec 31, 2013 | 18.40M | 33.33% |
| Dec 31, 2012 | 13.80M | -14.29% |
| Dec 30, 2011 | 16.10M | -99.83% |
| Dec 31, 2009 | 9.43B | -41.38% |
| Dec 31, 2008 | 16.09B | -53.23% |
| Dec 31, 2007 | 34.39B | 342.86% |
| Dec 29, 2006 | 7.77B | -22.22% |
| Dec 30, 2005 | 9.99B | - |
| Dec 31, 2004 | 9.99B | -73.66% |
| Dec 31, 2003 | 37.91B | 253.36% |
| Dec 31, 2002 | 10.73B | -73.01% |
| Dec 31, 2001 | 39.75B | 14.66% |
| Dec 29, 2000 | 34.67B | -41.18% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FSD Pharma | 5.59M |
| Synaptogenix | 5.54M |
| TransCode Therapeutics | 5.49M |
| Lixte Biotechnology Holdings | 5.38M |
| ENDRA Life Sciences | 5.35M |
| Leafly Holdings | 5.25M |
| Clearmind Medicine | 5.20M |
| Bright Minds Biosciences | 5.18M |